Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.
about
Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Co-delivery of the NKT agonist ...... promotes antitumor responses.
@en
Co-delivery of the NKT agonist ...... promotes antitumor responses.
@nl
type
label
Co-delivery of the NKT agonist ...... promotes antitumor responses.
@en
Co-delivery of the NKT agonist ...... promotes antitumor responses.
@nl
prefLabel
Co-delivery of the NKT agonist ...... promotes antitumor responses.
@en
Co-delivery of the NKT agonist ...... promotes antitumor responses.
@nl
P2093
P2860
P50
P1433
P1476
Co-delivery of the NKT agonist ...... promotes antitumor responses.
@en
P2093
Daphnée Soulard
Elodie Macho-Fernandez
Fathia Mami-Chouaib
François Trottein
Joel Plumas
Josette Fontaine
Julie De Meester
Luis Javier Cruz
Reem Ghinnagow
P2860
P304
P356
10.1080/2162402X.2017.1339855
P577
2017-08-18T00:00:00Z